Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.70 |
| ▸ | TSHR | P16473 | 4/20 | 0.52 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.52 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.52 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.52 |
| ▸ | PGR | P06401 | 1/20 | 0.52 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.52 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.52 |
| ▸ | HTR1A | P08908 | 1/20 | 0.52 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.52 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.52 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.52 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.52 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.52 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.52 |
| ▸ | CHRNA9 | Q9UGM1 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | GALR3 | O60755 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL189930 | 0.97 | ALDH1A1 (0.74) | ALDH1A1TSHRCHRM5CHRM1CHRM3 | |
| SCHEMBL273326 | 0.94 | ALDH1A1 (0.70) | ALDH1A1TSHRCHRM5CHRM1CHRM3 | |
| SCHEMBL11491818 | 0.94 | ALDH1A1 (0.70) | ALDH1A1TSHRCHRM5CHRM1CHRM3 | |
| SCHEMBL29414114 | 0.94 | ALDH1A1 (0.70) | ALDH1A1TSHRCHRM5CHRM1CHRM3 | |
| SCHEMBL4441760 | 0.94 | ALDH1A1 (0.70) | ALDH1A1TSHRCHRM5CHRM1CHRM3 | |
| SCHEMBL5136503 | 0.94 | ALDH1A1 (0.70) | ALDH1A1TSHRCHRM5CHRM1CHRM3 | |
| SCHEMBL8607908 | 0.94 | ALDH1A1 (0.70) | ALDH1A1TSHRCHRM5CHRM1CHRM3 | |
| SCHEMBL15299079 | 0.94 | ALDH1A1 (0.70) | ALDH1A1TSHRCHRM5CHRM1CHRM3 | |
| SCHEMBL11492305 | 0.94 | ALDH1A1 (0.70) | ALDH1A1TSHRCHRM5CHRM1CHRM3 | |
| SCHEMBL250642 | 0.94 | ALDH1A1 (0.70) | ALDH1A1TSHRCHRM5CHRM1CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220168336-A1 | NITRIC OXIDE RELEASING SUPPOSITORIES AND METHODS OF USE THEREOF | LNHC, INC. | 2022-06-02 | — | — | US | claimed |
| EP-3758679-A1 | NITRIC OXIDE RELEASING SUPPOSITORIES AND METHODS OF USE THEREOF | Novan, Inc. (US) | 2021-01-06 | — | — | EP | claimed |
| US-20200397815-A1 | NITRIC OXIDE RELEASING SUPPOSITORIES AND METHODS OF USE THEREOF | LIGAND PHARMACEUTICALS INCORPORATED | 2020-12-24 | — | — | US | claimed |
| WO-2024074894-A1 | POLYMERIC MICELLE NANOCARRIERS FOR TARGETED EPIDERMAL DELIVERY OF THE HEDGEHOG PATHWAY INHIBITOR TAK-441 | UNIVERSITÉ DE GENÈVE (CH) | 2024-04-11 | — | — | WO | disclosed |
| US-11813284-B2 | Topical compositions and methods of using the same | NOVAN, INC. (US) | 2023-11-14 | — | — | US | disclosed |
| US-20230330008-A1 | TOPICAL ANTIVIRAL COMPOSITIONS, DELIVERY SYSTEMS, AND METHODS OF USING THE SAME | LIGAND PHARMACEUTICALS INCORPORATED | 2023-10-19 | — | — | US | disclosed |
| EP-3579888-B1 | ELECTROCHEMICAL GASOTRANSMITTER GENERATING COMPOSITIONS AND METHODS OF USING SAME AND DRESSINGS AND TREATMENT SYSTEMS INCORPORATING SAME | NOXSANO INC (US) | 2023-09-27 | — | — | EP | disclosed |
| US-11723858-B2 | Topical antiviral compositions, delivery systems, and methods of using the same | NOVAN, INC. (US) | 2023-08-15 | — | — | US | disclosed |
| US-20230144853-A1 | TOPICAL COMPOSITIONS AND METHODS OF USING THE SAME | LNHC, INC. | 2023-05-11 | — | — | US | disclosed |
| US-11534382-B2 | Topical compositions and methods of using the same | NOVAN, INC. (US) | 2022-12-27 | — | — | US | disclosed |
| US-11369682-B2 | Light activated gasotransmitter generating compositions | Noxsano Inc. (US) | 2022-06-28 | — | — | US | disclosed |
| US-20160199295-A1 | TOPICAL COMPOSITIONS AND METHODS OF USING THE SAME | LIGAND PHARMACEUTICALS INCORPORATED | 2016-07-14 | — | — | US | disclosed |
| EP-3030266-A2 | TOPICAL COMPOSITIONS AND METHODS OF USING THE SAME | Novan Inc. (US) | 2016-06-15 | — | — | EP | disclosed |
| WO-2016022170-A1 | TOPICAL EMULSIONS | NOVAN, INC. (US) | 2016-02-11 | — | — | WO | disclosed |
| US-20160008275-A1 | TOPICAL COMPOSITIONS AND METHODS OF USING THE SAME | LIGAND PHARMACEUTICALS INCORPORATED | 2016-01-14 | — | — | US | disclosed |
| WO-2016007834-A1 | TOPICAL ANTIVIRAL COMPOSITIONS AND METHODS OF USING THE SAME | NOVAN, INC. (US) | 2016-01-14 | — | — | WO | disclosed |
| EP-2961382-A1 | TOPICAL COMPOSITIONS AND METHODS OF USING THE SAME | Novan Inc. (US) | 2016-01-06 | — | — | EP | disclosed |
| WO-2015021382-A2 | TOPICAL COMPOSITIONS AND METHODS OF USING THE SAME | NOVAN, INC. (US) | 2015-02-12 | — | — | WO | disclosed |
| WO-2014134502-A1 | TOPICAL COMPOSITIONS AND METHODS OF USING THE SAME | NOVAN, INC. (US) | 2014-09-04 | — | — | WO | disclosed |
| US-20140242023-A1 | Topical Compositions and Methods of Using the Same | NOVAN, INC. (US) | 2014-08-28 | — | — | US | disclosed |